Member Info for Fredd1eboy

Hi rabbit...their business model proposed a sale for gain well before phase 3.... Phase 3 is in a different spending/investment league

Agreed minnisage...We are all on tender hooks but have to accept what we are told....on trust...GM always believed the EGHO deal was a reasonable deal....I couldn't accept that at the time, and was enraged at the negative impact on the sp...but damage has been done.... amplified by short term wreckers...we now appear to be having moderate post exchanges and hopefully facts can be debated through sensible speculative posts. My initial one today is reminding that the EGHO is now past history.. I just hope we benefit from the IP we paid such heavy a price for....surely we must find out soon as for the price paid by us!!! each one of us!!!....I expect a game changer!!!!

Pl excuse spelling...I'm posting on the hoof

Pl excuse spelling...I'm posting on the hoof

* we have trials update by year end...from review team including eminent professor.
* GM has already stated "shareholder added value" coming through....you don't make that statement without dry ammunition in the breach.
* Vagaty surrounding EGHO pushed into touch.
*Rediculously low Val damaged by short term gainers about to be repaired.
That's enough for me!
But clearly dyor

Morning Valju, in reply to your kind post....Clearly a deal had two sides, and termination of same.
However, Val do not owe EGHO anything. There's nothing outstanding. The matter is closed and further uneccesary debate of a negative nature should be closed. Hopefully we look forward to good news during this final quarter, as promised!

Agreed valju....guess the only light we've had Is that nothing is owed to EGHO, in fact nothing was.....So hopefully, clarification of that, is the commencement of light beams flashing at the end of the tunnel. Fingers crossed..
Best wishes.
Fred

Fully agree Valju but today's BBC1 report is so relevant to Valirx....R&D has to be financed and if this terrible complaint can be cured from Valirx research....they need support...not just from us almost anialated investors but from NHS/associated institutional grant support. Yes, it's time for Val to deliver value added on their developed lines....delivered value added as promised.

Reminder c/o bossman ADVFN

Valirx are in CTs into this...

Dr Steve McConchie, co-founder and CEO of Aptus, added that his company was "delighted" to have been selected by ValiRx to work on the development plan options for VAL301 in endometriosis.
More than 13,500 women have taken part in BBC research revealing the devastating effect of endometriosis.

Half said they had had suicidal thoughts, and many said they rely on highly addictive painkillers.

Most also said endometriosis - involving painful periods - had badly affected their education, career and relationships.

MPs are to launch an inquiry into women's experiences of endometriosis following the research.

Women with the condition answered questions on how the condition has affected them. The charity Endometriosis UK helped gather the responses.

The condition affects one in 10 women and, as well as extremely heavy periods, can cause debilitating pain and sometimes infertility.

Exceptionally long video and following debate currently on BBC1.....surely opportunities for Val grant funding for fast tracking research.....need to latch on.....

...down 94% in one year.... primarily for missing end point on trials.
We've hopefully met ours and have other lines.....but hammered down for other reasons....
Hopefully we will be rewarded in the fullness of time despite so much poster negativity. I repeat hopefully!

ps. ..only got myself to blame.... naive and too trusting.

...news beforehand....chased to sp up and now taking profits.....it stinks...the entire aim stinks....and small genuine share holder get shafted.
After sustaining massive losses as a consequence of the banking crisis...I decided to invest remainder in ethical businesses...that was my mistake....entire funds now shrunk by 95%.....however hedge funds .....the rest is history...

My understanding is that Dr Lynch is part of a team and the team report...

1.473 for info

Words of wisdom.
First what is your PSA level today?
What was it yesterday and a year ago? Mark is the Principal Invistgator ie medic at UCLH "NOT" an assessor from any regulatory body and while has, and will be, an author on papers about the compound his status is that of a medic working on this trial; as are a number of other medic and scientific staff like: George. I'm sure he would suggest the best place to visit an accurate assessment of where things currently stand is the YTD report, together with accounts as announced a few days ago. I'm certain thats what he could advise.

Your last sentence pretty well accurately explains my feelings too!

Actual spread closing ..based on recent large buy...

A deal....Now wouldn't that, potentially, be a treat!

Almost three years ago!!!!!